Xu L - Search Results

1

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Chang C, Rajasekaran M, Qiao Y, Dong H, Wang Y, Xia H, Deivasigamani A, Wu M, Sekar K, Gao H, Sun M, Niu Y, Li Q, Tao L, Yan Z, Wang M, Chen S, Zhao S, Chen D, Li L, Yang F, Gao H, Chen B, Su L, Xu L, Chen Y, Seshachalam VP, Chen G, Gunaratne J, Hong W, Shi J, Chen G, Grierson DS, Chabot B, Xie T, Hui KM, Chen J. Chang C, et al. Among authors: xu l. Nat Commun. 2022 Mar 16;13(1):1363. doi: 10.1038/s41467-022-29016-x. Nat Commun. 2022. PMID: 35296659 Free PMC article.

2

The nuclear import function of Smad2 is masked by SARA and unmasked by TGFbeta-dependent phosphorylation.

Xu L, Chen YG, Massagué J. Xu L, et al. Nat Cell Biol. 2000 Aug;2(8):559-62. doi: 10.1038/35019649. Nat Cell Biol. 2000. PMID: 10934479 No abstract available.

3

The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai.

Chen S, Du H, Wang Y, Xu L. Chen S, et al. Among authors: xu l. Chin Med J (Engl). 1998 Mar;111(3):228-30. Chin Med J (Engl). 1998. PMID: 10374422

4

[Clinical study on niaodujing in treating chronic renal failure].

Wang YJ, Xu L, Cheng XX. Wang YJ, et al. Among authors: xu l. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996 Nov;16(11):649-51. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996. PMID: 9772612 Clinical Trial. Chinese.

5

Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma.

Chen Y, Xu L, Mayakonda A, Huang ML, Kanojia D, Tan TZ, Dakle P, Lin RY, Ke XY, Said JW, Chen J, Gery S, Ding LW, Jiang YY, Pang A, Puhaindran ME, Goh BC, Koeffler HP. Chen Y, et al. Among authors: xu l. Nat Commun. 2019 Mar 22;10(1):1353. doi: 10.1038/s41467-019-09257-z. Nat Commun. 2019. PMID: 30903020 Free PMC article.

6

Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth.

Chen Y, Huang Q, Liu W, Zhu Q, Cui CP, Xu L, Guo X, Wang P, Liu J, Dong G, Wei W, Liu CH, Feng Z, He F, Zhang L. Chen Y, et al. Among authors: xu l. Nat Commun. 2018 Jun 25;9(1):2464. doi: 10.1038/s41467-018-04815-3. Nat Commun. 2018. PMID: 29942010 Free PMC article.

7

Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.

Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G. Xu L, et al. Cancer Res. 2001 Apr 1;61(7):3176-81. Cancer Res. 2001. PMID: 11306505

8

Association of interleukin 18 gene polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery.

Chen S, Xu L, Tang J. Chen S, et al. Among authors: xu l. Tissue Antigens. 2010 Sep;76(3):245-9. doi: 10.1111/j.1399-0039.2010.01506.x. Tissue Antigens. 2010. PMID: 20522205

9

Core transcriptional regulatory circuitries in cancer.

Chen Y, Xu L, Lin RY, Müschen M, Koeffler HP. Chen Y, et al. Among authors: xu l. Oncogene. 2020 Oct;39(43):6633-6646. doi: 10.1038/s41388-020-01459-w. Epub 2020 Sep 17. Oncogene. 2020. PMID: 32943730 Free PMC article. Review.

10

Topography of transcriptionally active chromatin in glioblastoma.

Xu L, Chen Y, Huang Y, Sandanaraj E, Yu JS, Lin RY, Dakle P, Ke XY, Chong YK, Koh L, Mayakonda A, Nacro K, Hill J, Huang ML, Gery S, Lim SW, Huang Z, Xu Y, Chen J, Bai L, Wang S, Wakimoto H, Yeo TT, Ang BT, Müschen M, Tang C, Tan TZ, Koeffler HP. Xu L, et al. Among authors: xu y. Sci Adv. 2021 Apr 30;7(18):eabd4676. doi: 10.1126/sciadv.abd4676. Print 2021 Apr. Sci Adv. 2021. PMID: 33931443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,773 results

Search Page